Centro de Diagnóstico Molecular y Medicina Personalizada, Departamento de Ciencias Básicas, División Ciencias de la Salud, Universidad de Monterrey, San Pedro Garza García, NL, México.
About this institution
Publications Show all
A pharmacogenetic pilot study reveals MTHFR, DRD3, and MDR1 polymorphisms as biomarker candidates for slow atorvastatin ...
...Published in BMC Cancer
Australian New Zealand Clinical Trials Registry: ACTRN12614000851662, date registered: August 8, 2014.